In yesterday’s Wall Street session, Precipio Inc. (NASDAQ:PRPO) shares traded at $0.91, up 13.75% from the previous session.
As of this writing, 1 analysts cover Precipio Inc. (NASDAQ:PRPO). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $4.00 and a low of $4.00, we find $4.00. Given the previous closing price of $0.80, this indicates a potential upside of 400.0 percent. PRPO stock price is now 31.24% away from the 50-day moving average and -8.04% away from the 200-day moving average. The market capitalization of the company currently stands at $19.53M.
There are 0 analysts who have given it a hold rating, whereas 1 have given it a buy rating. Brokers who have rated the stock have averaged $4.00 as their price target over the next twelve months.
In other news, SANDBERG RICHARD A, Director bought 20,000 shares of the company’s stock on Jan 20. The stock was bought for $15,530 at an average price of $0.78. Upon completion of the transaction, the Director now directly owns 40,846 shares in the company, valued at $37169.86. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 03, Chief Operating Officer Sabet Ahmed Zaki bought 750 shares of the business’s stock. A total of $448 was incurred on buying the stock at an average price of $0.60. This leaves the insider owning 6,863 shares of the company worth $6245.33. A total of 0.20% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in PRPO stock. In total, there are 22 active investors with 9.60% ownership of the company’s stock.
Tuesday morning saw Precipio Inc. (NASDAQ: PRPO) opened at $0.8100. During the past 12 months, Precipio Inc. has had a low of $0.47 and a high of $1.77. As of last week, the company has a debt-to-equity ratio of 0.04, a current ratio of 1.70, and a quick ratio of 1.50. The fifty day moving average price for PRPO is $0.6934 and a two-hundred day moving average price translates $0.9896 for the stock.
The latest earnings results from Precipio Inc. (NASDAQ: PRPO) was released for Jun, 2022. According to the Diagnostics & Research Company, earnings per share came in at -$0.09, missing analysts’ expectations of -$0.08 by -0.01. This compares to -$0.08 EPS in the same period last year. The company reported revenue of $2.21 million for the quarter, compared to $2.25 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -1.38 percent. For the current quarter, analysts expect PRPO to generate $2.45M in revenue.
Precipio Inc.(PRPO) Company Profile
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.